Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma.
Saved in:
| Title: | Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma. |
|---|---|
| Authors: | Goldshmit Y; Department of Neurobiology, Tel-Aviv University, Ramat-Aviv, Israel. Australian Regenerative Medicine Institute, Monash University, Australia. These authors contributed equally to this work., Trangle SS; Department of Neurobiology, Tel-Aviv University, Ramat-Aviv, Israel. These authors contributed equally to this work., Kloog Y; Department of Neurobiology, Tel-Aviv University, Ramat-Aviv, Israel., Pinkas-Kramarski R; Department of Neurobiology, Tel-Aviv University, Ramat-Aviv, Israel. |
| Source: | Oncotarget [Oncotarget] 2014 Sep 30; Vol. 5 (18), pp. 8602-13. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 25261371 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Goldshmit+Y%22">Goldshmit Y</searchLink>; Department of Neurobiology, Tel-Aviv University, Ramat-Aviv, Israel. Australian Regenerative Medicine Institute, Monash University, Australia. These authors contributed equally to this work.<br /><searchLink fieldCode="AU" term="%22Trangle+SS%22">Trangle SS</searchLink>; Department of Neurobiology, Tel-Aviv University, Ramat-Aviv, Israel. These authors contributed equally to this work.<br /><searchLink fieldCode="AU" term="%22Kloog+Y%22">Kloog Y</searchLink>; Department of Neurobiology, Tel-Aviv University, Ramat-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Pinkas-Kramarski+R%22">Pinkas-Kramarski R</searchLink>; Department of Neurobiology, Tel-Aviv University, Ramat-Aviv, Israel. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101532965%22">Oncotarget</searchLink> [Oncotarget] 2014 Sep 30; Vol. 5 (18), pp. 8602-13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals%22">Impact Journals </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532965 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1949-2553 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219492553%22">19492553 </searchLink><i>NLM ISO Abbreviation: </i>Oncotarget <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25261371 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.18632/oncotarget.2343 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 8602 Titles: – TitleFull: Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Goldshmit Y – PersonEntity: Name: NameFull: Trangle SS – PersonEntity: Name: NameFull: Kloog Y – PersonEntity: Name: NameFull: Pinkas-Kramarski R IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 09 Text: 2014 Sep 30 Type: published Y: 2014 Identifiers: – Type: issn-electronic Value: 1949-2553 Numbering: – Type: volume Value: 5 – Type: issue Value: 18 Titles: – TitleFull: Oncotarget Type: main |
| ResultId | 1 |